Neoantigen-specific T cell help outperforms non-specific help in multi-antigen DNA vaccination against cancer

CD4+ T helper antigens are essential components of cancer vaccines, but the relevance of the source of these MHC class II-restricted antigens remains underexplored. To compare the effectiveness of tumor-specific versus tumor-unrelated helper antigens, we designed three DNA vaccines for the murine MC...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Joanna Fréderique de Graaf, Tamara Pesic, Felicia S. Spitzer, Koen Oosterhuis, Marcel G.M. Camps, Iris Zoutendijk, Bram Teunisse, Wahwah Zhu, Tsolere Arakelian, Gerben C. Zondag, Ramon Arens, Jeroen van Bergen, Ferry Ossendorp
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Elsevier 2024-09-01
Serie:	Molecular Therapy: Oncology
Ämnen:	MT: Regular Issue DNA vaccine cancer vaccine neoantigens personalized medicine immunotherapy
Länkar:	http://www.sciencedirect.com/science/article/pii/S2950329924000778
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!